Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2000 3
2001 5
2002 34
2003 33
2004 31
2005 51
2006 45
2007 37
2008 36
2009 45
2010 44
2011 42
2012 35
2013 40
2014 45
2015 55
2016 51
2017 64
2018 46
2019 45
2020 46
2021 49
Text availability
Article attribute
Article type
Publication date

Search Results

810 results
Results by year
Filters applied: . Clear all
Page 1
Chronic kidney disease.
Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ. Romagnani P, et al. Among authors: remuzzi g. Nat Rev Dis Primers. 2017 Nov 23;3:17088. doi: 10.1038/nrdp.2017.88. Nat Rev Dis Primers. 2017. PMID: 29168475 Review.
Podocytopathies.
Kopp JB, Anders HJ, Susztak K, Podestà MA, Remuzzi G, Hildebrandt F, Romagnani P. Kopp JB, et al. Among authors: remuzzi g. Nat Rev Dis Primers. 2020 Aug 13;6(1):68. doi: 10.1038/s41572-020-0196-7. Nat Rev Dis Primers. 2020. PMID: 32792490 Free PMC article. Review.
C3 glomerulopathy - understanding a rare complement-driven renal disease.
Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM. Smith RJH, et al. Among authors: remuzzi g. Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2. Nat Rev Nephrol. 2019. PMID: 30692664 Free PMC article. Review.
COVID-19 and Italy: what next?
Remuzzi A, Remuzzi G. Remuzzi A, et al. Among authors: remuzzi g. Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13. Lancet. 2020. PMID: 32178769 Free PMC article. Review.
Long-term follow-up of recovered patients with COVID-19.
Cortinovis M, Perico N, Remuzzi G. Cortinovis M, et al. Among authors: remuzzi g. Lancet. 2021 Jan 16;397(10270):173-175. doi: 10.1016/S0140-6736(21)00039-8. Epub 2021 Jan 8. Lancet. 2021. PMID: 33428868 Free PMC article. No abstract available.
Overview of complement activation and regulation.
Noris M, Remuzzi G. Noris M, et al. Among authors: remuzzi g. Semin Nephrol. 2013 Nov;33(6):479-92. doi: 10.1016/j.semnephrol.2013.08.001. Semin Nephrol. 2013. PMID: 24161035 Free PMC article. Review.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. Among authors: remuzzi g. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.
Estimated GFR: time for a critical appraisal.
Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G. Porrini E, et al. Among authors: remuzzi g. Nat Rev Nephrol. 2019 Mar;15(3):177-190. doi: 10.1038/s41581-018-0080-9. Nat Rev Nephrol. 2019. PMID: 30518813 Review.
810 results